/ Print /

PHARMACY BEST PRACTICES

Can Amazon change the pharmacy landscape?Industry experts analyze issues of mail delivery and transparency in the prescription drug market.
Opinion: Top 2 takeaways from Asembia Specialty Pharmacy SummitThe conference raised important points about value-based contracts and the specialty pharmacy space.
Top 3 strategies employers should use to decrease healthcare costsA new Willis Towers Watson survey finds that U.S. employers have three key strategies to building cost-effective healthcare programs. 
Fourteen things Trump needs to know about opioidsAs President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
Are non-opioid therapies more desirable than opioids for chronic pain?A new study from researchers from the Minneapolis VA Health Care System has interesting findings.
Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
What's missing in hep C drugsPayers have unmet needs in the changing hepatitis C (HCV) space, according to a recent survey. The survey, from Precision for Value, highlights what can be done to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment.
Opinion: Substance use disorder privacy law limits both payers, prescribersTwo University of Massachusetts Medical School pharmacists make the case to reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder.
Game-changing cholesterol-buster further reduces heart attack, strokeA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.
One plan’s unique approach to combat diabetes, obesityThis novel approach aims to help those already struggling with obesity and diabetes, but eventually win the fight against this epidemic.